Precision BioSciences, Inc.
Entity

  • Precision BioSciences, Inc.

    Created in 2006
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,365 20,347

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    SMB

  • Location

    302 E Pettigrew St, Durham, NC 27701, USA

    Durham

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 124

  • Engaged corporates

    3
    1 1

  • Added in Motherbase

    2 years, 7 months ago
Description
  • Value proposition

    Dedicated to Improving Life.

    Precision BioSciences, Inc. (Nasdaq: DTIL) is a pre-clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com.

    Gene Editing and Gene Therapy

Corporate interactions BETA
Corporate TypeTweets Articles
Biogen
Biogen
Biotechnology, Biotechnology Research
Biogen
Biotechnology, Biotechnology Research 		Other

13 Apr 2021


Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing 		Other

8 Mar 2019


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing 		Other

24 Jul 2022


Similar entities
Last news
Show all articles
Social network dynamics